National Vision Holdings, Inc. — Form 10-Q Summary
Reporting period: The filing covers the quarter and nine months ended September 30, 2017, compared with periods ended October 1, 2016. This conflicts with the request metadata identifying “2016 Q3”; the filing itself is for 2017 Q3.
Business context
National Vision is a value-focused optical retailer operating 996 stores across five brands, plus e-commerce and managed-vision-care businesses. Its reportable segments are Owned & Host and Legacy, which manages 227 vision centers in Walmart locations. The company reported 19 store openings in the quarter and 59 year to date.
Financial performance
| Metric | Q3 2017 | Q3 2016 | 9M 2017 | 9M 2016 |
|---|---|---|---|---|
| Net revenue | $346.1M | $301.2M | $1,053.5M | $919.1M |
| Operating income | $16.6M | $14.3M | $70.1M | $69.7M |
| Net income | $1.5M | $3.0M | $17.1M | $24.5M |
| Adjusted EBITDA (non-GAAP) | $36.2M | $30.7M | $134.7M | $116.8M |
| Operating margin | 4.8% | 4.8% | 6.6% | 7.6% |
| Net margin | 0.4% | 1.0% | 1.6% | 2.7% |
Revenue increased 14.9% in Q3 and 14.6% year to date. Adjusted comparable-store sales growth was 7.0% in Q3 and 6.7% year to date. Q3 growth was driven by comparable-store sales, new stores and AC Lens order volume. Gross cost of revenue increased as a share of revenue: total costs applicable to revenue were 46.9% in Q3 versus 46.0%, and 46.0% year to date versus 45.1%. Management cited higher optometrist costs and wholesale-fulfillment mix. SG&A fell as a share of revenue, but operating margins were flat in Q3 and lower year to date. Higher interest expense contributed to lower net income.
Cash flow and liquidity: Nine-month operating cash flow was $96.3M, investing cash outflow was $68.7M, and financing cash outflow was $4.8M; cash rose $22.7M to $27.6M. Capital expenditures were $67.1M year to date; management planned approximately $92.9M for fiscal 2017. At September 30, cash was $27.6M and revolver availability was $69.5M, net of letters of credit.
Debt: At September 30, the company had $794.0M of first-lien term loans and $125.0M of second-lien term loans outstanding. Variable-rate term debt was $927.4M at a weighted average rate of 4.5%; $500M was covered by interest-rate swaps. Management estimated that a 1 percentage-point rate increase would add approximately $4.3M of annual interest expense. The company reported covenant compliance at quarter-end.
Material changes and unusual items
- A February recapitalization dividend of $171.0M was funded with $175.0M of incremental first-lien borrowing. Interest expense rose year over year, partly due to this additional debt and hedge-related payments.
- Year-to-date results included a $7.0M litigation settlement charge, a $1.0M investment impairment and $2.3M in contact-lens inventory write-offs. The inventory issue also related to an identified control weakness; the filing says a prior-period error understated 2016 product costs by $2.1M and overstated 2016 net income by $1.3M, and was corrected in 2017.
- Hurricanes Harvey and Irma temporarily affected 203 stores. Management estimated a $3.5M–$4.1M revenue impact and a 1.5–1.7 percentage-point impact to Q3 comparable-store and adjusted comparable-store growth. One Houston-area store remained closed.
- Delayed federal tax refunds weighed on first-quarter transactions and revenue. Results are seasonal, with stronger revenue and cash flow typically in the first quarter.
- After quarter-end, the October 2017 IPO generated approximately $371.8M net proceeds; the company repaid all $125M of second-lien debt and approximately $235M of first-lien debt. In November, it refinanced remaining first-lien loans with $570M of new loans, extended maturity to November 2024 and reduced stated margins by 25 basis points, subject to rating-based terms.
Outlook, risks and contingencies
Management expected cash from operations and revolver availability to meet working-capital, liquidity, capital-spending and debt-payment needs for at least 12 months. It planned approximately 75 store openings in fiscal 2017 and expected continued depreciation growth as it invested in stores, technology, laboratories and distribution capacity. The filing provides no formal earnings or revenue guidance.
Key risks include execution of store expansion, recruitment and retention of vision-care professionals, reliance on major suppliers and the Walmart relationship, consumer spending and tax-refund timing, competition, information-security and privacy exposure, regulation, leases, and substantial leverage and variable-rate debt. The $7.0M contact-lens online-advertising settlement was preliminarily approved by the court after quarter-end; $3.5M was deposited into escrow. A separate California optometry-related class action had been dismissed with prejudice, but plaintiffs appealed.
Disclosure controls and procedures were deemed ineffective at quarter-end because two previously identified material weaknesses had not been remediated: controls over expired or expiring contact-lens inventory and entity-level controls for detecting business changes that could affect financial reporting. Management described remediation steps, but said the weaknesses would remain until controls operated effectively for a sufficient period and were tested.
Most important facts for investors to verify
- Confirm the period: the filing is for Q3 2017, despite the request metadata’s “2016 Q3” label.
- Track whether sales growth translates into improved margins and earnings, given rising product/service costs and interest expense.
- Assess post-IPO debt balances, refinancing terms, interest-rate exposure and the use of IPO proceeds.
- Monitor remediation and testing of the material weaknesses, particularly inventory valuation and financial-reporting controls.
- Verify settlement approval and payment, and follow the appeal in the California optometry litigation.
- Evaluate store-opening and capital-spending execution, alongside hurricane effects and the ongoing performance of military, Fred Meyer and Walmart-related operations.